297 related articles for article (PubMed ID: 21699780)
1. Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening.
Aikou S; Ohmoto Y; Gunji T; Matsuhashi N; Ohtsu H; Miura H; Kubota K; Yamagata Y; Seto Y; Nakajima A; Goldenring JR; Kaminishi M; Nomura S
Gastroenterology; 2011 Sep; 141(3):837-845.e1-7. PubMed ID: 21699780
[TBL] [Abstract][Full Text] [Related]
2. Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: a monocentric cohort study in China.
Huang Z; Zhang X; Lu H; Wu L; Wang D; Zhang Q; Ding H
BMC Gastroenterol; 2014 Apr; 14():74. PubMed ID: 24720760
[TBL] [Abstract][Full Text] [Related]
3. Influence of Helicobacter pylori status and eradication on the serum levels of trefoil factors and pepsinogen test: serum trefoil factor 3 is a stable biomarker.
Kaise M; Miwa J; Fujimoto A; Tashiro J; Tagami D; Sano H; Ohmoto Y
Gastric Cancer; 2013 Jul; 16(3):329-37. PubMed ID: 22907485
[TBL] [Abstract][Full Text] [Related]
4. The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk.
Kaise M; Miwa J; Tashiro J; Ohmoto Y; Morimoto S; Kato M; Urashima M; Ikegami M; Tajiri H
J Gastroenterol; 2011 Jun; 46(6):736-45. PubMed ID: 21455714
[TBL] [Abstract][Full Text] [Related]
5. Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer.
Lee JY; Park KS; Lee HG; Baek WK; Cho KB; Lee YJ; Lee YS; Ryu SW
Clin Exp Med; 2017 Aug; 17(3):403-410. PubMed ID: 27154568
[TBL] [Abstract][Full Text] [Related]
6. Serum Level of Trefoil Factor 2 can Predict the Extent of Gastric Spasmolytic Polypeptide-Expressing Metaplasia in the H. pylori-Infected Gastric Cancer Relatives.
Kuo HY; Chang WL; Yeh YC; Tsai YC; Wu CT; Cheng HC; Yang HB; Lu CC; Sheu BS
Helicobacter; 2017 Feb; 22(1):. PubMed ID: 27220894
[TBL] [Abstract][Full Text] [Related]
7. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.
Leung WK; Yu J; Chan FK; To KF; Chan MW; Ebert MP; Ng EK; Chung SC; Malfertheiner P; Sung JJ
J Pathol; 2002 Aug; 197(5):582-8. PubMed ID: 12210076
[TBL] [Abstract][Full Text] [Related]
8. Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer.
Ishibashi Y; Ohtsu H; Ikemura M; Kikuchi Y; Niwa T; Nishioka K; Uchida Y; Miura H; Aikou S; Gunji T; Matsuhashi N; Ohmoto Y; Sasaki T; Seto Y; Ogawa T; Tada K; Nomura S
Sci Rep; 2017 Jul; 7(1):4846. PubMed ID: 28687783
[TBL] [Abstract][Full Text] [Related]
9. Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer.
Qu Y; Yang Y; Ma D; Xiao W
Oncol Rep; 2012 Apr; 27(4):1277-83. PubMed ID: 22246423
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of trefoil factors are increased in patients with advanced prostate cancer.
Vestergaard EM; Borre M; Poulsen SS; Nexø E; Tørring N
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):807-12. PubMed ID: 16467092
[TBL] [Abstract][Full Text] [Related]
11. [Trefoil factor family gene and peptide expression in pterygium].
Lafontaine PO; Arnal M; Buron N; Solary E; Lizard S; Bron A; Bara J; Gespach C; Creuzot-Garcher C
J Fr Ophtalmol; 2003 Dec; 26(10):1007-14. PubMed ID: 14691392
[TBL] [Abstract][Full Text] [Related]
12. Promoter polymorphisms in trefoil factor 2 and trefoil factor 3 genes and susceptibility to gastric cancer and atrophic gastritis among Chinese population.
Xu Q; Chen MY; He CY; Sun LP; Yuan Y
Gene; 2013 Oct; 529(1):104-12. PubMed ID: 23933418
[TBL] [Abstract][Full Text] [Related]
13. Validation of commercial assays for measurements of trefoil factor family peptides in serum.
Samson MH; Nexo E
Clin Chem Lab Med; 2011 Sep; 49(12):2057-60. PubMed ID: 21923477
[TBL] [Abstract][Full Text] [Related]
14. Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2.
Warson C; Van De Bovenkamp JH; Korteland-Van Male AM; Büller HA; Einerhand AW; Ectors NL; Dekker J
Hum Pathol; 2002 Jun; 33(6):660-8. PubMed ID: 12152167
[TBL] [Abstract][Full Text] [Related]
15. Trefoil factors and human gastric cancer (review).
Katoh M
Int J Mol Med; 2003 Jul; 12(1):3-9. PubMed ID: 12792801
[TBL] [Abstract][Full Text] [Related]
16. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
17. The Association of Trefoil Factors with Gastric Cancer and Premalignant Lesions: A Cross-Sectional Population-Based Cohort Study.
Zan X; Chen Z; Guo Q; Wang Y; Zhang Z; Ji R; Zheng Y; Zhang J; Wu Z; Li M; Wang X; Ye Y; Li X; An F; Xu C; Lu L; Fan P; Zhang J; Guan Q; Li Q; Liu M; Ren Q; Hu X; Lu H; Wang Y; Zhang H; Zhao Y; Gou X; Shu X; Wang J; Hu Z; Liu R; Yuan H; Liu J; Qiao L; Zhou Y
Cancer Epidemiol Biomarkers Prev; 2022 Mar; 31(3):625-632. PubMed ID: 35027436
[TBL] [Abstract][Full Text] [Related]
18. Association between Promoter Polymorphisms of TFF1, TFF2, and TFF3 and the Risk of Gastric and Diffuse Gastric Cancers in a Korean Population.
Jin EH; Lee SI; Kim J; Seo EY; Lee SY; Hur GM; Shin S; Hong JH
J Korean Med Sci; 2015 Aug; 30(8):1035-41. PubMed ID: 26240479
[TBL] [Abstract][Full Text] [Related]
19. Injected TFF1 and TFF3 bind to TFF2-immunoreactive cells in the gastrointestinal tract in rats.
Poulsen SS; Thulesen J; Hartmann B; Kissow HL; Nexø E; Thim L
Regul Pept; 2003 Sep; 115(2):91-9. PubMed ID: 12972324
[TBL] [Abstract][Full Text] [Related]
20. Immunoassays of human trefoil factors 1 and 2: measured on serum from patients with inflammatory bowel disease.
Vestergaard EM; Brynskov J; Ejskjaer K; Clausen JT; Thim L; Nexø E; Poulsen SS
Scand J Clin Lab Invest; 2004 Apr; 64(2):146-56. PubMed ID: 15115253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
